Early in the pandemic, the rapid adoption of telehealth in the United States offset some of the declines in doctor visits during lockdowns and requirements in hospitals and medical practices.

Telehealth visits in the United States accounted for less than 1% of visits prior to the pandemic, rose to 26% in April 2020 at the height of the pandemic, and declined to 5% over the last half of 2022.

Slight increases in the use of telehealth in the United States can be seen during times of increased COVID-19 activity (i.e., December 2020, January 2022) as phone or video visits, particularly for those suspected of having COVID-19, as telehealth visits can be used to reduce the spread of the virus.

As of the end of 2022, 43 states required commercial insurers to reimburse for telehealth, although only 24 states have laws addressing payment parity between face-to-face and telehealth visits.1

You can read the IQVIA 2023 report on the use of medicines in the US by clicking here. Access the IQVIA website and additional 2023 reports here.

Telehealth trends in the United States vs. face-to-face visits.

References

  1. The Use of Medicines in the U.S. 2023. (n.d.). IQVIA. https://www.iqvia.com/insights/the-iqvia-institute/reports/the-use-of-medicines-in-the-us-2023

Disclaimers

  • The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
  • Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
  • No official support by any organization(s) has been provided or should be inferred